Glycobiology Is Witnessing Significant Adoption Due To Increasing Applications In Pharmaceutical Drug Development And Industrial Biotechnology
Glycobiology is one of two major branches of science that focuses on the metabolic makeup of various carbohydrates and starches. More precisely, defined in the broadest sense, glycobiology is the research of the molecular biology, structure, and physiology of diverse saccharides which are commonly found in nature. It is a rapidly growing field, with a wide variety of scientific disciplines involved in its study. Glycobiology has played an important role in the understanding of many conditions and diseases that have contemporary therapeutic potential. Among these are disorders that have symptoms similar to those seen in diabetes, such as Type I and Type II diabetes, as well as metabolic disorders like that of fatty liver disease (fatty liver).
The field of glycobiology has
developed out of the basic studies of carbohydrates and how they are broken
down. These studies have shown that the best approach to treating many
metabolic disorders is by addressing their underlying energy source. For
instance, in the case of insulin resistance, it has been discovered that
glucose or refined carbohydrates are not able to provide the energy required to
satisfy body requirements. This can be remedied through the introduction of
proteins that can bridge the gap between blood sugar and energy pathways.
Glycobiology also includes
applications in other areas of science. The field has had applications in many
aspects of engineering, including computer chip design, pharmaceutical drug
development, biomedical and industrial biotechnology, and chemical engineering.
In addition, the field of glycobiology has had applications in veterinary
science, as animals are exposed to high levels of glucose at a low level. In
fact, glycogen is often used as a source of energy for laboratory animals. The
field of glycobiology continues to grow with exciting new developments and
applications in all areas of science. Increasing R&D expenditure by
pharmaceutical and the presence of robust healthcare infrastructure in the U.S.
is expected to boost glycobiology research.
Comments
Post a Comment